drugset / Trial / NCT00136734

Methylphenidate Treatment for Cocaine Abuse and ADHD - 1

NCT00136734 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

Many cocaine dependent individuals are also diagnosed with Attention Deficit Hyperactivity Disorder (ADHD). Methylphenidate (Ritalin) is currently approved to treat individuals diagnosed with ADHD. The purpose of this study is to determine the effectiveness of methylphenidate in treating ADHD symptoms in cocaine dependent individuals.

Timeline

Start
1998-04
Primary completion
2004-03
Completion
2004-03

Outcome

Missed primary endpoint

paper Although sustained-release MPH did not show superiority over PBO in treating ADHD symptoms PMID 16930863 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylphenidate Small molecule 40 mg —
Subject Methylphenidate Small molecule 60 mg —